2018 ReviewYear ended March 2018

Scroll to learn more

Meiji's Business

The Meiji Group provides customers of all ages ―from infants to seniors― with a wide range of products for healthy and fulfilling lives. From delicious confectionaries and wholesome dairy products to body-enhancing nutrition supplements and vital pharmaceuticals, we make people's wellness our main mission.

Meiji's Business

Key Figures

Net Sales
¥1,240.8 billion
0.1%
Operating Income Ratio
7.6 %
0.5 percentage points
Capital Expenditures
¥71.7 billion
Operating Income
¥94.6 billion
7.1%
ROE
13.1 %
0.9 percentage points
R&D Expenses
¥26.5 billion

Breakdown by Segment

Breakdown by Segment

Business Performance Analysis

Food

Net Sales
¥1,073.6 billion
0.8%
Operating Income
¥84.1 billion
1.5%

Income Analysis

Pharmaceuticals

Net Sales
¥168.4 billion
4.2%
Operating Income
¥11.0 billion
90.7%

Income Analysis

Capital Expenditures

Capital Expenditures

Food

¥63.8 billion

Pharmaceuticals

¥7.8 billion

Cash Dividends per Share / Dividend Payout Ratio

Dividend Payout Ratio / Cash Dividends per Share

Future Prospects

It is the first year of our Medium - Term Business Plan, FYE March 2019 through FYE March 2021.
Our consolidated earnings forecast is as follows:

FYE 3/2018
Results
Net sales ¥1,240.8 billion
Operating income ¥94.6 billion
Operating income ratio 7.6%
ROE 13.1%

FYE 3/2019
Targets
¥1,260.0 billion
¥99.5 billion
7.9%
12.4%

(as of May 11, 2018)